Pharvaris N.V. Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019
Pharvaris N.V. (PHVS) reported Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 of 14.74 EUR/shares for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-02.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 · last filed 2026-04-02
| Period end | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 12 month |
|---|---|
| 2025-12-31 | 14.74 EUR/shares 20-F · filed 2026-04-02 |
| 2024-12-31 | 19.79 EUR/shares 20-F · filed 2026-04-02 |
| 2023-12-31 | 6.53 EUR/shares 20-F · filed 2026-04-02 |
| 2022-12-31 | 16.12 EUR/shares 20-F · filed 2025-04-07 |
| 2021-12-31 | 15.80 EUR/shares 20-F · filed 2024-04-10 |
| 2020-12-31 | 2.53 EUR/shares 20-F · filed 2022-03-29 |
| 2019-12-31 | 0.00 EUR/shares 20-F · filed 2021-04-29 |